Filter Results:
(3)
Show Results For
- All HBS Web
(9)
- Faculty Publications (3)
Show Results For
- All HBS Web
(9)
- Faculty Publications (3)
CRISPR
→
Page 1 of 3
Results
- October 2020 (Revised June 2021)
- Case
What Will Best Serve Humanity? Accelerating Uses for CRISPR at the Broad Institute
By: Amitabh Chandra, Matthew C. Weinzierl, Lisa Marrone and Spencer Lee-Rey
Chandra, Amitabh, Matthew C. Weinzierl, Lisa Marrone, and Spencer Lee-Rey. "What Will Best Serve Humanity? Accelerating Uses for CRISPR at the Broad Institute." Harvard Business School Case 721-018, October 2020. (Revised June 2021.)
- February 2020 (Revised June 2021)
- Case
CRISPR and the Ethics of Germline Editing
By: Amitabh Chandra, Spencer Lee-Rey and Douglas Melton
Chandra, Amitabh, Spencer Lee-Rey, and Douglas Melton. "CRISPR and the Ethics of Germline Editing." Harvard Business School Case 620-101, February 2020. (Revised June 2021.)
- October 2016 (Revised September 2017)
- Case
The CRISPR-Cas9 Quarrel
By: Richard G. Hamermesh and Matthew G. Preble
In mid-2016, the Broad Institute and the University of California, Berkeley were in the middle of a contentious patent dispute over which entity controlled a breakthrough gene editing technology called CRISPR-Cas9. With CRISPR-Cas9, scientists might soon be able to... View Details
Keywords: CRISPR; Broad Institute; University Of California Berkeley; Intellectual Property; Patents; Law; Lawsuits and Litigation; Science; Genetics; Entrepreneurship; Biotechnology Industry; United States
Hamermesh, Richard G., and Matthew G. Preble. "The CRISPR-Cas9 Quarrel." Harvard Business School Case 817-020, October 2016. (Revised September 2017.)